Zafgen

Dedicated to the treatment of obesity.

• 
• 
• 
• 
• 
• 
• 

News

October 26, 2009
Zafgen, Inc. to Present at Upcoming Conferences

June 9, 2009
Zafgen Scientific Advisory Board Member Randy Seeley, Ph.D., Receives Outstanding Scientific Achievement Award at American Diabetes Association Annual Meeting

June 8, 2009
Groundbreaking Approach to Treating Obesity Highlighted by Keynote Lecture at American Diabetes Association Annual Scientific Sessions

May 14, 2009
Zafgen, Inc. Announces Participation at BIO 2009 International Convention

May 5, 2009
Zafgen, Inc. Appoints Matthias Jaffe to Chief Financial Officer and Vice President of Business Development

April 27, 2009
Zafgen, Inc. to Present at Xconomy Forum

March 25, 2009
Zafgen, Inc. to Present at Upcoming Conferences

January 29, 2009
Argenta Discovery and Zafgen Announce Contract Drug Discovery Collaboration in Obesity

October 16, 2008
Zafgen Inc. to Present at First Annual Boston Biotech R&D Conference

September 9, 2008
Zafgen Inc. Appoints Industry Veteran and Recognized Metabolic Disorders Expert Thomas Hughes, Ph.D., as Company’s First Chief Executive Officer

Cao, Y. Angiogenesis modulates adipogenesis and obesity. The Journal of Clinical Investigation. Volume 117, Number 9. September 2007.

Lijnen, H.R. Angiogenesis and obesity. The European Society of Cardiology 2007.

Ukropec, J., Ukropcova, B., Kurdiova, T., Gasperikova, D., Klimes, I. Archives of Physiology and Biochemistry.